These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 22831800
21. Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group. Gao XH, Zhou C, Liu HR, Liu LB, Tang JJ, Xia XH. J Enzyme Inhib Med Chem; 2017 Dec; 32(1):146-152. PubMed ID: 27801600 [Abstract] [Full Text] [Related]
22. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors. Sheng R, Lin X, Zhang J, Chol KS, Huang W, Yang B, He Q, Hu Y. Bioorg Med Chem; 2009 Sep 15; 17(18):6692-8. PubMed ID: 19692250 [Abstract] [Full Text] [Related]
23. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Huang L, Shi A, He F, Li X. Bioorg Med Chem; 2010 Feb 15; 18(3):1244-51. PubMed ID: 20056426 [Abstract] [Full Text] [Related]
24. Design, synthesis, biological evaluation and docking study of 5-oxo-4,5-dihydropyrano[3,2-c]chromene derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors. Khoobi M, Alipour M, Sakhteman A, Nadri H, Moradi A, Ghandi M, Emami S, Foroumadi A, Shafiee A. Eur J Med Chem; 2013 Oct 15; 68():260-9. PubMed ID: 23988409 [Abstract] [Full Text] [Related]
25. Synthesis of tacrine-lophine hybrids via one-pot four component reaction and biological evaluation as acetyl- and butyrylcholinesterase inhibitors. da Costa JS, Lopes JP, Russowsky D, Petzhold CL, Borges AC, Ceschi MA, Konrath E, Batassini C, Lunardi PS, Gonçalves CA. Eur J Med Chem; 2013 Apr 15; 62():556-63. PubMed ID: 23422935 [Abstract] [Full Text] [Related]
26. Synthesis, biological evaluation and molecular modeling of substituted 2-aminobenzimidazoles as novel inhibitors of acetylcholinesterase and butyrylcholinesterase. Zhu J, Wu CF, Li X, Wu GS, Xie S, Hu QN, Deng Z, Zhu MX, Luo HR, Hong X. Bioorg Med Chem; 2013 Jul 15; 21(14):4218-24. PubMed ID: 23719283 [Abstract] [Full Text] [Related]
27. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors. Chen SC, Qiu GL, Li B, Shi JB, Liu XH, Tang WJ. Eur J Med Chem; 2018 Mar 10; 147():194-204. PubMed ID: 29438888 [Abstract] [Full Text] [Related]
28. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors. Więckowska A, Bajda M, Guzior N, Malawska B. Eur J Med Chem; 2010 Dec 10; 45(12):5602-11. PubMed ID: 20926161 [Abstract] [Full Text] [Related]
30. Design, synthesis, docking study and biological evaluation of some novel tetrahydrochromeno [3',4':5,6]pyrano[2,3-b]quinolin-6(7H)-one derivatives against acetyl- and butyrylcholinesterase. Khoobi M, Alipour M, Moradi A, Sakhteman A, Nadri H, Razavi SF, Ghandi M, Foroumadi A, Shafiee A. Eur J Med Chem; 2013 Oct 10; 68():291-300. PubMed ID: 23988412 [Abstract] [Full Text] [Related]
31. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine. Yu Q, Greig NH, Holloway HW, Brossi A. J Med Chem; 1998 Jun 18; 41(13):2371-9. PubMed ID: 9632370 [Abstract] [Full Text] [Related]
32. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease. Korabecny J, Musilek K, Holas O, Binder J, Zemek F, Marek J, Pohanka M, Opletalova V, Dohnal V, Kuca K. Bioorg Med Chem Lett; 2010 Oct 15; 20(20):6093-5. PubMed ID: 20817518 [Abstract] [Full Text] [Related]
33. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase. Alipour M, Khoobi M, Nadri H, Sakhteman A, Moradi A, Ghandi M, Foroumadi A, Shafiee A. Arch Pharm (Weinheim); 2013 Aug 15; 346(8):577-87. PubMed ID: 23852709 [Abstract] [Full Text] [Related]
34. Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives. Alipour M, Khoobi M, Moradi A, Nadri H, Homayouni Moghadam F, Emami S, Hasanpour Z, Foroumadi A, Shafiee A. Eur J Med Chem; 2014 Jul 23; 82():536-44. PubMed ID: 24941128 [Abstract] [Full Text] [Related]
35. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors. Parlar S, Bayraktar G, Tarikogullari AH, Alptüzün V, Erciyas E. Chem Pharm Bull (Tokyo); 2016 Jul 23; 64(9):1281-7. PubMed ID: 27581632 [Abstract] [Full Text] [Related]
37. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine. Luo W, Yu QS, Zhan M, Parrish D, Deschamps JR, Kulkarni SS, Holloway HW, Alley GM, Lahiri DK, Brossi A, Greig NH. J Med Chem; 2005 Feb 24; 48(4):986-94. PubMed ID: 15715468 [Abstract] [Full Text] [Related]
38. Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives. Liu H, Fan H, Gao X, Huang X, Liu X, Liu L, Zhou C, Tang J, Wang Q, Liu W. J Enzyme Inhib Med Chem; 2016 Aug 24; 31(4):580-9. PubMed ID: 26186269 [Abstract] [Full Text] [Related]